Sequencing Technology

The funding will also support a partnership developing agricultural educational and training opportunities for students in genomics and bioinformatics.

The gene fusion assay maker is the sixth member to join the consortium, which also includes Illumina and several pharmaceutical companies.

The Center for Human Genetics and Laboratory Medicine's Prenatalis test is based on Illumina's Verifi technology. 

Qiagen believes it has gained access to a relatively simple and inexpensive technology to bolster its offerings in the growing single-cell molecular biology market.

Birmingham Women's NHS Foundation Trust said it is partnering with Illumina to develop an NIPT, which it hopes to start offering in September.

Direct sensing bioFETs and methods of manufacture
Pen-shaped device for biological sample preparation and analysis
Devices and methods for biological sample preparation
Methods for treating infection involving identification of a carbapanemase gene
Artificial DNA sequence with optimized leader function in 5' (5'-UTR) for the improved expression of heterologous proteins in plants
Methods and compositions for amplification of nucleic acids

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Sep
17
Sponsored by
Omicia

This online seminar will provide examples of how commercial and hospital-affiliated clinical labs are successfully developing and deploying high-throughput next-generation sequencing-based testing services for genetic diseases. 

Oct
15
Sponsored by
Parabase

This webinar will discuss the benefits of a rapid targeted next-generation sequencing (TNGS) panel, using dried blood spots, for second-tier newborn metabolic and hearing loss screening and its immediate utility for high-risk diagnostic testing in the neonatal intensive care unit.